| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9643564 | Journal of the American Academy of Child & Adolescent Psychiatry | 2005 | 8 Pages |
Abstract
This study indicates the effectiveness of risperidone during a period of several months, reducing disruptive behavior in about half of the children with autism spectrum disorders. The results provide a rationale for the continuing use of risperidone beyond 6 months, although considerable weight gain can limit the use of this agent.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Pieter W. M.D., Bertine E. M.D., Mark-Peter M.S., Cees E.J. M.D., Ph.D., Jan K. M.D., Ph.D., Herman M.D., Ph.D., Lawrence M.S.N., Ph.D., Ruud B. M.D., Ph.D., Pieter J. M.D., Ph.D.,